NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch » TOP 50 Pharmas » Johnson & Johnson  1    
found files: 9
Johnson & Johnson »15/04/2007 [Company watch]
Johnson & Johnson Buys China’s Dabao

China ‚Äôs largest cosmetic manufacturer, Dabao, has reportedly been bought by Johnson and Johnson (J&J) for 2.3 billion Yuan (approximately US$299 million)....   more»

Johnson & Johnson »20/11/2007 [Company watch]
Johnson & Johnson to Hold 70% of Xi'an-Janssen

Johnson & Johnson Ltd. (NYSE: JNJ), plans to buy more shares in Xi'an-Janssen Pharmaceutical Ltd. from the latter's Chinese shareholders, according to an insider from the pharmaceutical joint venture on November 20, 2007. The buyer is in negotiations with three Chinese shareholders to acquire a 17.2% stake in the joint venture on the base that the equity structure of the sellers would not change. The acquisition has been approved by China's Ministry of Commerce, said the insider. The deal might enlarge Johnson & Johnson's holding in Xi'an-Janssen to 70% from currently 52%. Johnson & Johnson (China) Investment has recently acquired 1.8% of Xi'an-Janssen for CNY 78 million from Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. The other three Chinese shareholders are Shaanxi Pharmaceutical Industry Corporation with a 33.6% stake; China National Pharmaceutical Industry Corporation 5.76%; and China National Pharmaceutical Foreign Trade Corporation 3.84%. Xi'an-Janssen was jointly set up by Belgium-based Janssen Pharmaceutica NV of Johnson & Johnson and the four Chinese state-owned companies in October 1985....   more»

Johnson & Johnson »28/02/2008 [Company watch]
Johnson & Johnson to establish cancer center in Tianjin

Johnson & Johnson signed a letter of intent with the Tianjin Medical University Cancer Institute and Hospital on February 26 to finance the construction of the Tianjin - Johnson Cancer Cooperation Development Centre in the Tiajin Binhai New Area. Tianjin Medical University's Cancer Institute and Hospital is a leading research base for cancer prevention and treatment, housing one of the most advanced tumor tissue banks in China....   more»

Johnson & Johnson »20/02/2008 [Company watch]
Johnson & Johnson 2007 Results

Revenues (up) $61,100 Millions Net Profit (down) $ 10,576 millions R & D Spend $ 8,487 Millions...   more»

Johnson & Johnson »11/07/2008 [Company watch]
J&J sets up diabetes institute in Beijing

J&J sets up diabetes institute in Beijing Johnson & Johnson has established a diabetes institute as of July 11 in Beijing, the fourth non-profit institute financed by the company worldwide. The new institute will focus on providing training for Chinese diabetes professionals and developing a disease management model for diabetes. China had 39.8 million diabetes patients in 2007, second only to India....   more»

Johnson & Johnson »21/03/2009 [Company watch]
China clears Johnson & Johnson baby products after probe

Chinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by U.S. company Johnson & Johnson....   more»

Johnson & Johnson »27/03/2009 [Company watch]
Parents file lawsuit against J & J

About 80 families are to file a lawsuit against Johnson & Johnson claiming the company\'s products have harmed their children. Their lawyers say they will submit cases to grass-root courts in Beijing at the beginning of April....   more»

Johnson & Johnson
»26/07/2009 [Company watch]
J&J Wins Approval to Market MDS Drug Without China Trials

Xian-Janssen, a division of Johnson & Johnson has launched a new drug in China. Dacogen (decitabine), a novel treatment for myelodysplastic syndrome, received SFDA approval through the Green Channel, an expedited approval process that the SFDA introduced in January 2009....   more»

Johnson & Johnson
»14/05/2010 [Company watch]
Johnson & Johnson Creates R&D Centre with Tianjin Cancer Hospital

Johnson & Johnson Pharmaceutical Research Group will join Tianjin Medical University Cancer Hospital to build a Joint R&D Center in Oncology, which will be housed at the Tianjin Cancer Hospital....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.